Solara Active Pharma Sciences Limited Financial Ratios
SOLARA · Healthcare · Current price ₹650
P/E ratio
-2081.9x
P/B ratio
2.7x
ROE
-0.6%
ROCE
4.5%
Debt / Equity
0.55
Dividend yield
0.4%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | -2081.9x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 2.7x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -0.6% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 4.5% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.55 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Solara Active Pharma Sciences Limited's latest numbers.
Solara Active Pharma Sciences Limited profitability
Solara Active Pharma Sciences Limited generates a return on equity of -0.6% and a return on capital employed of 4.5%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.55 and a P/E of -2081.9x, Solara Active Pharma Sciences Limited is moderately leveraged. Our overall business-quality score for the company is 2.9 / 10.
Understand the ratios
More on Solara Active Pharma Sciences Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.